These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 588557)

  • 41. The mechanism of activation of bovine prothrombin by an activator isolated from Echis carinatus venon and characterization of the new active intermediates.
    Morita T; Iwanaga S; Suzuki T
    J Biochem; 1976 May; 79(5):1089-108. PubMed ID: 956136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Thrombin: a multifunctional enzyme].
    Polack B
    Ann Biol Clin (Paris); 2003; 61(1):23-31. PubMed ID: 12604383
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protein engineering thrombin for optimal specificity and potency of anticoagulant activity in vivo.
    Tsiang M; Paborsky LR; Li WX; Jain AK; Mao CT; Dunn KE; Lee DW; Matsumura SY; Matteucci MD; Coutré SE; Leung LL; Gibbs CS
    Biochemistry; 1996 Dec; 35(51):16449-57. PubMed ID: 8987977
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human alpha- to zeta-thrombin cleavage occurs with neutrophil cathepsin G or chymotrypsin while fibrinogen clotting activity is retained.
    Brezniak DV; Brower MS; Witting JI; Walz DA; Fenton JW
    Biochemistry; 1990 Apr; 29(14):3536-42. PubMed ID: 2354150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemical modification of alpha-thrombin and in vitro characterization of its anticoagulant activity.
    Nakagomi K; Ajisaka K
    Biochem Int; 1990 Oct; 22(1):75-84. PubMed ID: 2177988
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Direct thrombin inhibitor-bivalirudin functionalized plasma polymerized allylamine coating for improved biocompatibility of vascular devices.
    Yang Z; Tu Q; Maitz MF; Zhou S; Wang J; Huang N
    Biomaterials; 2012 Nov; 33(32):7959-71. PubMed ID: 22877639
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Noncompetitive inhibitor of thrombin.
    Koh CY; Kazimirova M; Nuttall PA; Kini RM
    Chembiochem; 2009 Sep; 10(13):2155-8. PubMed ID: 19644995
    [No Abstract]   [Full Text] [Related]  

  • 48. Inhibition of thrombin and autoprothrombin C (F-X a ) as a mutual depletion system.
    Dombrose FA; Seegers WH; Sedensky JA
    Thromb Diath Haemorrh; 1971 Aug; 26(1):103-23. PubMed ID: 5112369
    [No Abstract]   [Full Text] [Related]  

  • 49. Formation of activated protein C and inactivation of cell-bound thrombin by antithrombin III at the surface of cultured vascular endothelial cells--a comparative study of two anticoagulant mechanisms.
    Delvos U; Meusel P; Preissner KT; Müller-Berghaus G
    Thromb Haemost; 1987 Feb; 57(1):87-91. PubMed ID: 3590084
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interaction of the 268-282 region of glycoprotein Ibalpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII.
    De Cristofaro R; De Filippis V
    Biochem J; 2003 Jul; 373(Pt 2):593-601. PubMed ID: 12689334
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-resolution NMR studies of fibrinogen-like peptides in solution: structural basis for the bleeding disorder caused by a single mutation of Gly(12) to Val(12) in the A alpha chain of human fibrinogen Rouen.
    Ni F; Konishi Y; Bullock LD; Rivetna MN; Scheraga HA
    Biochemistry; 1989 Apr; 28(7):3106-19. PubMed ID: 2742828
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Apolipoprotein-E degradation in human very low density lipoproteins by plasma protease(s): chemical and biological consequences.
    Bradley WA; Gilliam EB; Gotto AM; Gianturco SH
    Biochem Biophys Res Commun; 1982 Dec; 109(4):1360-7. PubMed ID: 6301435
    [No Abstract]   [Full Text] [Related]  

  • 53. [Protein C anticoagulant pathway and its abnormality].
    Suzuki K
    Seikagaku; 1993 Nov; 65(11):1386-401. PubMed ID: 8294777
    [No Abstract]   [Full Text] [Related]  

  • 54. Specific fragmentation of natural inhibitor of mitochondrial ATPase by thrombin.
    Dianoux AC; Freyssinet JM
    Biochem Biophys Res Commun; 1982 Jul; 107(2):435-41. PubMed ID: 6215037
    [No Abstract]   [Full Text] [Related]  

  • 55. Structure and function of protein C.
    Stenflo J
    Semin Thromb Hemost; 1984 Apr; 10(2):109-21. PubMed ID: 6429858
    [No Abstract]   [Full Text] [Related]  

  • 56. Thrombin inhibition by cyclic peptides from thrombomodulin.
    Lougheed JC; Bowman CL; Meininger DP; Komives EA
    Protein Sci; 1995 Apr; 4(4):773-80. PubMed ID: 7613475
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C.
    Esmon NL; Owen WG; Esmon CT
    J Biol Chem; 1982 Jan; 257(2):859-64. PubMed ID: 6895633
    [No Abstract]   [Full Text] [Related]  

  • 58. Influence of protein C activation on blood coagulation and fibrinolysis in squirrel monkeys.
    Colucci M; Stassen JM; Collen D
    J Clin Invest; 1984 Jul; 74(1):200-4. PubMed ID: 6547456
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Severe antigenic deficiency of protein C associated with moderate deficiency of protein C activity.
    Melissari E; Scully MF; Ellis V; Kakkar VV
    Thromb Res; 1985 Sep; 39(5):641-4. PubMed ID: 3841234
    [No Abstract]   [Full Text] [Related]  

  • 60. Isolation and characterization of an acidic glycoprotein from normal bovine plasma.
    BEZKOROVAINY A; DOHERTY DG
    Arch Biochem Biophys; 1962 Mar; 96():491-9. PubMed ID: 13868776
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.